These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25117499)

  • 21. X-CHIP: an integrated platform for high-throughput protein crystallization and on-the-chip X-ray diffraction data collection.
    Kisselman G; Qiu W; Romanov V; Thompson CM; Lam R; Battaile KP; Pai EF; Chirgadze NY
    Acta Crystallogr D Biol Crystallogr; 2011 Jun; 67(Pt 6):533-9. PubMed ID: 21636893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AutoDrug: fully automated macromolecular crystallography workflows for fragment-based drug discovery.
    Tsai Y; McPhillips SE; González A; McPhillips TM; Zinn D; Cohen AE; Feese MD; Bushnell D; Tiefenbrunn T; Stout CD; Ludaescher B; Hedman B; Hodgson KO; Soltis SM
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):796-803. PubMed ID: 23633588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentle, fast and effective crystal soaking by acoustic dispensing.
    Collins PM; Ng JT; Talon R; Nekrosiute K; Krojer T; Douangamath A; Brandao-Neto J; Wright N; Pearce NM; von Delft F
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):246-255. PubMed ID: 28291760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput protein crystallography and drug discovery.
    Tickle I; Sharff A; Vinkovic M; Yon J; Jhoti H
    Chem Soc Rev; 2004 Oct; 33(8):558-65. PubMed ID: 15480479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electron density guided fragment-based drug design--a lead generation example.
    Abad MC; Gibbs AC; Zhang X
    Methods Enzymol; 2011; 493():487-508. PubMed ID: 21371603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPR-based fragment screening: advantages and applications.
    Neumann T; Junker HD; Schmidt K; Sekul R
    Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid-access, high-throughput synchrotron crystallography for drug discovery.
    Wasserman SR; Koss JW; Sojitra ST; Morisco LL; Burley SK
    Trends Pharmacol Sci; 2012 May; 33(5):261-7. PubMed ID: 22521107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the successful generation of protein-ligand complex crystals.
    Müller I
    Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):79-92. PubMed ID: 28177304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
    Gill A; Cleasby A; Jhoti H
    Chembiochem; 2005 Mar; 6(3):506-12. PubMed ID: 15696598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovering novel ligands for macromolecules using X-ray crystallographic screening.
    Nienaber VL; Richardson PL; Klighofer V; Bouska JJ; Giranda VL; Greer J
    Nat Biotechnol; 2000 Oct; 18(10):1105-8. PubMed ID: 11017052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lead generation and examples opinion regarding how to follow up hits.
    Orita M; Ohno K; Warizaya M; Amano Y; Niimi T
    Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein crystallography and fragment-based drug design.
    Caliandro R; Belviso DB; Aresta BM; de Candia M; Altomare CD
    Future Med Chem; 2013 Jun; 5(10):1121-40. PubMed ID: 23795969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
    Yokoyama T; Kitakami R; Mizuguchi M
    Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated crystal mounting and data collection for protein crystallography.
    Muchmore SW; Olson J; Jones R; Pan J; Blum M; Greer J; Merrick SM; Magdalinos P; Nienaber VL
    Structure; 2000 Dec; 8(12):R243-6. PubMed ID: 11188700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hitting the target: fragment screening with acoustic in situ co-crystallization of proteins plus fragment libraries on pin-mounted data-collection micromeshes.
    Yin X; Scalia A; Leroy L; Cuttitta CM; Polizzo GM; Ericson DL; Roessler CG; Campos O; Ma MY; Agarwal R; Jackimowicz R; Allaire M; Orville AM; Sweet RM; Soares AS
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1177-89. PubMed ID: 24816088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis.
    Ginn HM
    Acta Crystallogr D Struct Biol; 2020 Nov; 76(Pt 11):1134-1144. PubMed ID: 33135684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment-based drug discovery and its application to challenging drug targets.
    Price AJ; Howard S; Cons BD
    Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.